You raise an interesting point re PE ratios.
This could well be back to historic revenues in 18 months (my prediction ) however it does not mean the share price and therefore the PE will appreciate back to its old highs as this will not priced to the same extent for its growth potential as before plus there will have been considerable dilution in the interim .
- Forums
- ASX - By Stock
- FLT
- Equity raise process
Equity raise process, page-23
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FLT (ASX) to my watchlist
|
|||||
Last
$22.56 |
Change
0.610(2.78%) |
Mkt cap ! $4.986B |
Open | High | Low | Value | Volume |
$22.20 | $22.61 | $21.97 | $28.02M | 1.252M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2440 | $22.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$22.57 | 8445 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2440 | 22.540 |
1 | 433 | 22.520 |
1 | 418 | 22.500 |
2 | 994 | 22.490 |
1 | 2774 | 22.480 |
Price($) | Vol. | No. |
---|---|---|
22.570 | 288 | 2 |
22.580 | 300 | 2 |
22.600 | 453 | 1 |
22.620 | 919 | 2 |
22.630 | 735 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
FLT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online